Ziren Kong - Search Results

Year	Number of Results
2010	1
2012	1
2013	1
2017	1
2018	4
2019	8
2020	14
2021	11
2022	7
2023	3
2024	5

1

Vaccination in the immunotherapy of glioblastoma.

Kong Z, Wang Y, Ma W. Kong Z, et al. Hum Vaccin Immunother. 2018 Feb 1;14(2):255-268. doi: 10.1080/21645515.2017.1388481. Epub 2017 Dec 11. Hum Vaccin Immunother. 2018. PMID: 29087782 Free PMC article. Review.

2

Covalent targeted radioligands potentiate radionuclide therapy.

Cui XY, Li Z, Kong Z, Liu Y, Meng H, Wen Z, Wang C, Chen J, Xu M, Li Y, Gao J, Zhu W, Hao Z, Huo L, Liu S, Yang Z, Liu Z. Cui XY, et al. Among authors: kong z. Nature. 2024 May 22. doi: 10.1038/s41586-024-07461-6. Online ahead of print. Nature. 2024. PMID: 38778111

3

The role of PET/CT in radiotherapy for nasopharyngeal carcinoma.

Li H, Kong Z, Xiang Y, Zheng R, Liu S. Li H, et al. Among authors: kong z. Front Oncol. 2022 Oct 21;12:1017758. doi: 10.3389/fonc.2022.1017758. eCollection 2022. Front Oncol. 2022. PMID: 36338692 Free PMC article. Review.

4

Effects of oncolytic viruses and viral vectors on immunity in glioblastoma.

Liu P, Wang Y, Wang Y, Kong Z, Chen W, Li J, Chen W, Tong Y, Ma W, Wang Y. Liu P, et al. Among authors: kong z. Gene Ther. 2022 Apr;29(3-4):115-126. doi: 10.1038/s41434-020-00207-9. Epub 2020 Nov 15. Gene Ther. 2022. PMID: 33191399 Review.

5

Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas.

Kong Z, Yan C, Zhu R, Wang J, Wang Y, Wang Y, Wang R, Feng F, Ma W. Kong Z, et al. Neuroimage Clin. 2018 Jul 5;20:51-60. doi: 10.1016/j.nicl.2018.07.001. eCollection 2018. Neuroimage Clin. 2018. PMID: 30069427 Free PMC article. Review.

6

PD-1/PD-L1 immune checkpoint inhibitors in glioblastoma: clinical studies, challenges and potential.

Yang T, Kong Z, Ma W. Yang T, et al. Among authors: kong z. Hum Vaccin Immunother. 2021 Feb 1;17(2):546-553. doi: 10.1080/21645515.2020.1782692. Epub 2020 Jul 9. Hum Vaccin Immunother. 2021. PMID: 32643507 Free PMC article. Review.

7

Central Nervous System Germ Cell Tumors: A Review of the Literature.

Kong Z, Wang Y, Dai C, Yao Y, Ma W, Wang Y. Kong Z, et al. J Child Neurol. 2018 Aug;33(9):610-620. doi: 10.1177/0883073818772470. Epub 2018 May 30. J Child Neurol. 2018. PMID: 29848146 Review.

8

Oncogenesis, Microenvironment Modulation and Clinical Potentiality of FAP in Glioblastoma: Lessons Learned from Other Solid Tumors.

Shi Y, Kong Z, Liu P, Hou G, Wu J, Ma W, Cheng X, Wang Y. Shi Y, et al. Among authors: kong z. Cells. 2021 May 10;10(5):1142. doi: 10.3390/cells10051142. Cells. 2021. PMID: 34068501 Free PMC article. Review.

9

Pretreatment Geriatric Assessments of Elderly Patients with Glioma: Development and Implications.

Wang Y, Zhao B, Chen W, Liu L, Chen W, Zhou L, Kong Z, Dai C, Wang Y, Ma W. Wang Y, et al. Among authors: kong z. Aging Dis. 2020 Mar 9;11(2):448-461. doi: 10.14336/AD.2019.0527. eCollection 2020 Apr. Aging Dis. 2020. PMID: 32257553 Free PMC article. Review.

10

86Y-Labeled Albumin-Binding Fibroblast Activation Protein Inhibitor for Late-Time-Point Cancer Diagnosis.

Ding J, Xu M, Chen J, Zhang P, Huo L, Kong Z, Liu Z. Ding J, et al. Among authors: kong z. Mol Pharm. 2022 Sep 5;19(9):3429-3438. doi: 10.1021/acs.molpharmaceut.2c00579. Epub 2022 Aug 17. Mol Pharm. 2022. PMID: 35976352

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

47 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year